Lira2 – Effects on subclinical heartfailure in type 2 diabetic subjects on liraglutide treatment versus glimepiride both in combination with metformin. Prematurely terminated. Start year: 2014
LIRA2 Official title: Effects on subclinical heartfailure in type 2 diabetic subjects on liraglutide treatment versus glimepiride both in combination with metformin. Prematurely terminatedTrial start year: 2014 Trial websiteNo website available Trial registrationEudraCT: 2014-001778-32View registration Design paperNo design paper published Result paperNo result paper published